US FDA’s Rare Pediatric Voucher Program Faces Tight Deadline For Reauthorization

Sunset
The rare pediatric disease PRV program is scheduled to start sunsetting on 1 October. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from United States